| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/18/2000 | US6051587 Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
| 04/18/2000 | US6051585 Single-dose antihistamine/decongestant formulations for treating rhinitis |
| 04/18/2000 | US6051584 Viricides; fungicides; bactericides |
| 04/18/2000 | US6051583 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1H-benz[f]indoles, processes for preparing them and their use as pharmaceutical compositions |
| 04/18/2000 | US6051581 Spiro-azabicyclic compounds useful in therapy |
| 04/18/2000 | US6051580 Neurokinin antagonist; antiasthma agent |
| 04/18/2000 | US6051579 Viricide for herpes virus |
| 04/18/2000 | US6051578 Pyrazolopyrimidines for treatment of CNS disorders |
| 04/18/2000 | US6051577 N-7-heterocyclyl pyrrolo[2,3-D]pyrimidines and the use thereof |
| 04/18/2000 | US6051576 Means to achieve sustained release of synergistic drugs by conjugation |
| 04/18/2000 | US6051573 Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists |
| 04/18/2000 | US6051571 Methods for treating medical dysfunctions and diseases using furan nitrone compounds |
| 04/18/2000 | US6051570 Benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them |
| 04/18/2000 | US6051569 1'S, 5R, 6R-carbapenem derivatives and antimicrobial agents comprising the same |
| 04/18/2000 | US6051568 Thrombin inhibitors, their preparation and use |
| 04/18/2000 | US6051566 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation |
| 04/18/2000 | US6051565 Farnesyl-protein transferase inhibitors |
| 04/18/2000 | US6051564 Phosphatidic acid-comprising compositions |
| 04/18/2000 | US6051563 Methods for the administration of amifostine and related compounds |
| 04/18/2000 | US6051560 Prevention eye injuries from trauma during surgery |
| 04/18/2000 | US6051375 Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses |
| 04/18/2000 | US6051259 Composition for sustained release of human growth hormone |
| 04/18/2000 | US6051256 Dispersible macromolecule compositions and methods for their preparation and use |
| 04/18/2000 | US6051255 Polymer coated tablet comprising amoxycillin and clavulanate |
| 04/18/2000 | US6051254 Amoxycillin hydrate, an effervescent couple, beta.-lactamase inhibitor; the effervescent couple comprises an acid component and an alkaline component |
| 04/18/2000 | US6051252 Compacted ribavirin composition substantially free of other ribavirin polymorphic forms. |
| 04/18/2000 | US6051251 Liposome loading method using a boronic acid compound |
| 04/18/2000 | US6051243 Polyaromatic amide compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 04/18/2000 | US6051241 Administering to a patient in need thereof an effective amount of a gaseous medication comprising nitrogen monoxide and carbon dioxide by intra-abdominal route for treatment or prevention of hypoperfusions of abdominal organs |
| 04/18/2000 | US6051234 Health diet for preventing diseases caused by life-habit |
| 04/18/2000 | US6051227 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 04/18/2000 | US6051221 BRK protein tyrosine kinase and encoding nucleic acid |
| 04/18/2000 | US6051218 Administering cell expressing interleukin-3 |
| 04/18/2000 | CA2166700C Heterocyclic amines having central nervous system activity |
| 04/18/2000 | CA2158678C Use of 5-thia-1, 4-diazabicyclo/4.2.0/octane-3,8-dioxo compounds in antitumor therapy |
| 04/18/2000 | CA2087604C Diamine compounds and cerebral protective drugs containing the same |
| 04/18/2000 | CA2069485C Delayed release formulations |
| 04/18/2000 | CA2030344C Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds |
| 04/18/2000 | CA2010180C Pesticidal 3-cyano-5-alkoxy-1-arylpyrazoles |
| 04/18/2000 | CA1340962C Arylhydrazones |
| 04/18/2000 | CA1340961C 2', 3' - dideoxy - 2' - fluoronucleosides |
| 04/18/2000 | CA1340960C Chroman derivatives |
| 04/16/2000 | CA2252144A1 Dual action anticancer prodrugs |
| 04/16/2000 | CA2251414A1 Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use |
| 04/15/2000 | CA2284853A1 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds |
| 04/13/2000 | WO2000061108A1 Pharmaceutical aerosol formulation |
| 04/13/2000 | WO2000020645A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-α (TNF-α) EXPRESSION |
| 04/13/2000 | WO2000020642A1 Prevention of adhesions |
| 04/13/2000 | WO2000020636A1 Methods of identifying inverse agonists of the serotonin 2a receptor |
| 04/13/2000 | WO2000020635A1 ANTISENSE MODULATION OF INTEGRIN α4 EXPRESSION |
| 04/13/2000 | WO2000020625A1 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction |
| 04/13/2000 | WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | WO2000020603A1 Altered fatty acid biosynthesis in insect cells using delta five desaturase |
| 04/13/2000 | WO2000020602A2 Delta 6 and delta 12 desaturases and modified fatty acid biosynthesis and products produced therefrom |
| 04/13/2000 | WO2000020601A2 Polyketide synthase enzymes and recombinant dna constructs therefor |
| 04/13/2000 | WO2000020587A2 Cancer associated antigens and uses therefor |
| 04/13/2000 | WO2000020576A2 Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein |
| 04/13/2000 | WO2000020575A1 Pollinosis-associated gene |
| 04/13/2000 | WO2000020570A1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 04/13/2000 | WO2000020556A2 Zinc finger-reactive antimicrobial compounds |
| 04/13/2000 | WO2000020458A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 04/13/2000 | WO2000020450A2 Calcium channel alpha-2/delta gene |
| 04/13/2000 | WO2000020448A2 Nlk1 -interacting proteins |
| 04/13/2000 | WO2000020437A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 04/13/2000 | WO2000020435A1 ANTISENSE MODULATION OF EXPRESSION OF TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS (TRAFs) |
| 04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | WO2000020432A1 Antisense modulation of bcl-x expression |
| 04/13/2000 | WO2000020423A1 Tricyclic δ3-piperidines as pharmaceuticals |
| 04/13/2000 | WO2000020422A1 BENZOTHIENO[3,2-c]PYRIDINES AS α2 ANTAGONISTS |
| 04/13/2000 | WO2000020421A2 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS |
| 04/13/2000 | WO2000020420A1 Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance |
| 04/13/2000 | WO2000020419A1 Photosensitizers for photodynamic applications |
| 04/13/2000 | WO2000020418A1 Xanthobaccin antibiotics |
| 04/13/2000 | WO2000020416A1 Imidazo[4,5-c-]-pyridine-4-one derivatives with factor xa inhibiting effect |
| 04/13/2000 | WO2000020413A1 Novel 2-[3-phenyl-2-propenyl]-1,2,3,4-tetrahydroxyisoquinoline derivatives, preparation method and use as fungicides |
| 04/13/2000 | WO2000020411A1 Cytotoxic alkaloids (halitulin) |
| 04/13/2000 | WO2000020410A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 04/13/2000 | WO2000020402A1 Chemical compounds |
| 04/13/2000 | WO2000020401A1 New bis-benzimidazoles |
| 04/13/2000 | WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | WO2000020396A1 Phenylalkanoic acid derivatives as inhibitors of alpha4 integrins |
| 04/13/2000 | WO2000020395A1 New crystal modification iii of torasemide |
| 04/13/2000 | WO2000020394A1 Benzamide derivatives as thrombin inhibitors |
| 04/13/2000 | WO2000020393A1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 04/13/2000 | WO2000020392A1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
| 04/13/2000 | WO2000020391A1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 04/13/2000 | WO2000020390A1 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 04/13/2000 | WO2000020389A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000020388A1 Indolin derivatives as sun protection agents |
| 04/13/2000 | WO2000020387A1 Remedies for motor dysfunction and gapdh expression inhibitors |
| 04/13/2000 | WO2000020382A1 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators |
| 04/13/2000 | WO2000020379A1 Monoalkyl quats |
| 04/13/2000 | WO2000020378A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 04/13/2000 | WO2000020376A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | WO2000020371A1 Prostaglandin receptor ligands |
| 04/13/2000 | WO2000020370A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | WO2000020365A1 A process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds |
| 04/13/2000 | WO2000020358A2 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
| 04/13/2000 | WO2000020281A1 Polyurethane foam materials with skin conditioning additives |